Results 1 to 10 of about 33,349 (194)

Human Papillomavirus Vaccines. [PDF]

J Infect Dis, 2021
Abstract Human papillomavirus (HPV) vaccines are among the most effective vaccines available, the first to prevent infection by a mucosatropic sexually transmitted infectious agent and to do so without specific induction of mucosal immunity.
Markowitz LE, Schiller JT.
europepmc   +4 more sources

Human Papillomavirus Vaccines: An Updated Review [PDF]

Vaccines, 2020
Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past decade, have shown promising results in decreasing HPV infection and related diseases, such as warts and precancerous lesions. In this review, we present the updated
Liqin Cheng, Yan Wang, Juan Du
doaj   +2 more sources

Human Papillomavirus Vaccines

Reviews in Medical Virology, 2006
AbstractA wealth of epidemiological and molecular evidence has led to the conclusion that virtually all cases of cervical cancer and its precursor intra‐epithelial lesions are a result of infection with one or other of a subset of genital human papillomaviruses (HPVs) suggesting that prevention of infection by prophylactic vaccination would be an ...
Mia R, Schmiedeskamp, Denise R, Kockler
europepmc   +6 more sources

A Pocket Manual for Human Papillomavirus Vaccines [PDF]

Vaccines
Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide and is responsible for the majority of cervical, anal, and vaginal cancers. The first prophylactic HPV vaccine was introduced in the United States in 2006.
Natalie A. Voss, J. Brooks Jackson, Mary B. Rysavy   +2 more
doaj   +2 more sources

Human papillomavirus vaccines. [PDF]

CMAJ, 2017
Human papillomavirus is the most common sexually transmitted infection. Persistent infection with a high-risk HPV type causes virtually all cases of cervical cancer and has been associated with 90% of anal, 70% of vaginal, 40% of vulvar and 65% of penile cancers,[1][1] as well as up to 70 ...
Ismail SJ, Deeks SL.
europepmc   +4 more sources

Potential Benefits of Second-Generation Human Papillomavirus Vaccines [PDF]

PLoS ONE, 2012
Current prophylactic vaccines against human papillomavirus (HPV) target two oncogenic types (16 and 18) that contribute to 70% of cervical cancer cases worldwide.
Jane Kim
exaly   +2 more sources

Human papillomavirus vaccines: A great leap forward [PDF]

Case Reports in Women's Health, 2022
Marie Louise Frevert, Florin-Andrei Taran   +1 more
doaj   +2 more sources

Papillomavirus vaccines [PDF]

Frontiers in Bioscience, 1998
The considerable morbidity and mortality associated with certain human papillomaviruses (HPV) has provided the impetus for HPV vaccine development. The design of such vaccines has evolved from an understanding of the nature of HPV infections and their consequences, together with evaluation of the efficacy of different approaches to vaccination in ...
Duggan-Keen, M, Brown, MD, Stacey, S, Stern, PL.   +3 more
openaire   +4 more sources

Current status and future directions for the development of human papillomavirus vaccines [PDF]

Frontiers in Immunology
Liangzhi Xie
exaly   +2 more sources

Knowledge and attitudes of mothers toward HPV vaccination: A cross-sectional study in Kazakhstan

Women's Health, 2023
Background: Although recommended for all member states of World Health Organization, there is no national human papillomavirus vaccination program in Kazakhstan.
Aisha Babi, Torgyn Issa, Alpamys Issanov, Sholpan Akhanova, Natalya Udalova, Svetlana Koktova, Askhat Balykov, Zhanna Sattarkyzy, Balkenzhe Imankulova, Nazira Kamzayeva, Wassim Y. Almawi, Gulzhanat Aimagambetova   +11 more
doaj   +1 more source